Anita Kapur

Statistics

Publications

Citations

533

H-Index

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

University of Delhi

Durham University

Virginia Commonwealth University

Anita Kapur is an author at GlaxoSmithKline (United States) specializing in clinical pharmacology, pharmacology, and sodium-glucose cotransporter 2 inhibition.

Publications per year

1987–2015

Publications

Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2

Suzanne E. Barbour, Anita Kapur, Clifford L Deal · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 1999 · 93 citations

Life Sciences, Biochemistry, Cell Biology +14

Remogliflozin etabonate, a selective inhibitor of the sodium‐dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients

Robert L. Dobbins, R. O’Connor‐Semmes, Anita Kapur et al. · Diabetes Obesity and Metabolism · 2011 · 76 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus

Anita Kapur, Robin O'Connor‐Semmes, Elizabeth K. Hussey et al. · BMC Pharmacology and Toxicology · 2013 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Sequence analysis of the long arm of rice chromosome 11 for rice?wheat synteny

Saurabh Raghuvanshi, Subodh K. Srivastava, Ajit K. Pal et al. · Functional & Integrative Genomics · 2004 · 46 citations

Life Sciences, Genetics, Plant Biology +14

Multiple‐Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double‐Blind Study

Elizabeth K. Hussey, Robert L. Dobbins, R Stoltz et al. · The Journal of Clinical Pharmacology · 2010 · 46 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

1–5 of 14